Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
MetricValuePeriodScopeSource row
Revenue¥974m2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥3.0bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income−¥547m2025-04-01 → 2025-09-30Cons.Operating income
Operating income−¥149m2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income−¥483m2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥45m2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥103m2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax−¥483m2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax−¥103m2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)−¥486m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥103m2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥104m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income−¥486m2025-04-01 → 2025-09-30Cons.Profit loss
Net income−¥104m2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥9.4bnat 2025-09-30Cons.Assets
Total assets¥9.7bnat 2025-03-31Cons.Assets
Total assets¥9.4bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥688mat 2025-09-30Cons.Liabilities
Total liabilities¥686mat 2025-03-31Cons.Liabilities
Net assets / equity¥8.7bnat 2025-09-30Cons.Net assets
Net assets / equity¥9.0bnat 2025-03-31Cons.Net assets
Net assets / equity¥8.7bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥2.8bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥2.6bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow−¥342m2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥6m2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥131m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥123m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥796m2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥412m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥680m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥681m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-5.142025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.112024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.142024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio92.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio92.9%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.8%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2025-04-01 → 2025-09-30−¥341m
Medical Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥87m
Medical Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥87m
Medical Businessreportable segmentsegment ordinary income2025-04-01 → 2025-09-30−¥119m
Research Support Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥887m
Research Support Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥887m
Research Support Businessreportable segmentsegment ordinary income2025-04-01 → 2025-09-30−¥23m
—segment totalrevenue2025-04-01 → 2025-09-30¥974m
—segment totalrevenue external2025-04-01 → 2025-09-30¥974m
—segment totalsegment ordinary income2025-04-01 → 2025-09-30−¥142m
Reconciling Itemsreconcilingsegment ordinary income2024-04-01 → 2024-09-30−¥378m
Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥176m
Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥176m
Medical Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥8m
Research Support Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.1bn
Research Support Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.1bn
Research Support Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥267m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.3bn
—segment totalsegment ordinary income2024-04-01 → 2024-09-30¥275m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 470
ItemContextValueUnit
Number of shares heldInterimInstant_No2MajorShareholdersMember832400
Shareholding ratioInterimInstant_No2MajorShareholdersMember0.0087
Number of shares heldInterimInstant_No3MajorShareholdersMember828600
Shareholding ratioInterimInstant_No3MajorShareholdersMember0.0087
Number of shares heldInterimInstant_No4MajorShareholdersMember646900
Shareholding ratioInterimInstant_No4MajorShareholdersMember0.0068
Number of shares heldInterimInstant_No5MajorShareholdersMember500000
Shareholding ratioInterimInstant_No5MajorShareholdersMember0.0052
Number of shares heldInterimInstant_No6MajorShareholdersMember459064
Shareholding ratioInterimInstant_No6MajorShareholdersMember0.0048
Number of shares heldInterimInstant_No7MajorShareholdersMember453900
Shareholding ratioInterimInstant_No7MajorShareholdersMember0.0047
Number of shares heldInterimInstant_No8MajorShareholdersMember403644
Shareholding ratioInterimInstant_No8MajorShareholdersMember0.0042
Number of shares heldInterimInstant_No9MajorShareholdersMember380000
Shareholding ratioInterimInstant_No9MajorShareholdersMember0.0040
Number of shares heldInterimInstant_No10MajorShareholdersMember351000
Shareholding ratioInterimInstant_No10MajorShareholdersMember0.0037
Number of shares heldInterimInstant5962458
Shareholding ratioInterimInstant0.0629
Number of shares issued shares voting rightsInterimInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember117200
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember94640300
Number of voting rights issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember946403
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesSharesLessThanOneUnitMember45391
Number of shares issued shares voting rightsInterimInstant94802891
Number of voting rights issued shares voting rightsInterimInstant946403
Number of shares held in own name treasury shares etcInterimInstant_Row1Member117200
Number of shares held in others names treasury shares etcInterimInstant_Row1Member-
Total number of shares held treasury shares etcInterimInstant_Row1Member117200
Shareholding ratio treasury shares etcInterimInstant_Row1Member0.0012
Number of shares held in own name treasury shares etcInterimInstant117200
Number of shares held in others names treasury shares etcInterimInstant-
Total number of shares held treasury shares etcInterimInstant117200
Shareholding ratio treasury shares etcInterimInstant0.0012
Cash and depositsPrior1YearInstant2823367000JPY
Cash and depositsInterimInstant2635132000JPY
Accounts receivable tradePrior1YearInstant463933000JPY
Accounts receivable tradeInterimInstant329291000JPY
Short term investment securitiesPrior1YearInstant1118245000JPY
Short term investment securitiesInterimInstant3115987000JPY
Merchandise and finished goodsPrior1YearInstant132991000JPY
Merchandise and finished goodsInterimInstant132344000JPY
Work in processPrior1YearInstant61118000JPY
Work in processInterimInstant84725000JPY
Raw materials and suppliesPrior1YearInstant76248000JPY
Raw materials and suppliesInterimInstant87207000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass